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Abstract	  
Objective	  
Spinal	  Muscular	  Atrophy	  (SMA)	  is	  a	  major	  inherited	  cause	  of	  infant	  death	  worldwide.	  
It	  results	  from	  mutations	  in	  a	  single,	  ubiquitously	  expressed	  gene	  (SMN1),	  with	  loss	  
of	  lower	  motor	  neurons	  being	  the	  primary	  pathological	  signature.	  Systemic	  defects	  
have	  also	  been	  reported	  in	  SMA	  patients	  and	  animal	  models.	  We	  investigated	  
whether	  defects	  associated	  with	  the	  vasculature	  contribute	  to	  motor	  neuron	  
pathology	  in	  SMA.	  
Methods	  
Development	  and	  integrity	  of	  the	  capillary	  bed	  was	  examined	  in	  skeletal	  muscle	  and	  
spinal	  cord	  of	  SMA	  mice,	  and	  muscle	  biopsies	  from	  SMA	  patients	  and	  controls,	  using	  
quantitative	  morphometric	  approaches	  on	  immunohistochemically-­‐labelled	  tissue.	  
Pimonidazole	  hydrochloride-­‐based	  assays	  were	  used	  to	  identify	  functional	  hypoxia.	  
Results	  
The	  capillary	  bed	  in	  muscle	  and	  spinal	  cord	  was	  normal	  in	  pre-­‐symptomatic	  SMA	  
mice	  (post-­‐natal	  day	  1),	  but	  failed	  to	  match	  subsequent	  post-­‐natal	  development	  in	  
control	  littermates.	  At	  mid-­‐	  and	  late-­‐symptomatic	  time-­‐points	  the	  extent	  of	  the	  
vascular	  architecture	  observed	  in	  two	  distinct	  mouse	  models	  of	  SMA	  was	  ~50%	  of	  
that	  observed	  in	  control	  animals.	  Skeletal	  muscle	  biopsies	  from	  human	  patients	  
confirmed	  the	  presence	  of	  developmentally	  similar,	  significant	  vascular	  depletion	  in	  
severe	  SMA.	  Hypovascularity	  in	  SMA	  mouse	  spinal	  cord	  was	  accompanied	  by	  
significant	  functional	  hypoxia	  and	  defects	  in	  the	  blood-­‐spinal	  cord	  barrier.	  
Interpretation	  
Our	  results	  indicate	  that	  vascular	  defects	  are	  a	  major	  feature	  of	  severe	  forms	  of	  
SMA,	  present	  in	  both	  mouse	  models	  and	  patients,	  resulting	  in	  functional	  hypoxia	  of	  
motor	  neurons.	  Thus,	  abnormal	  vascular	  development	  and	  resulting	  hypoxia	  may	  
contribute	  to	  the	  pathogenesis	  of	  SMA.	  
	   	  
Introduction	  
Spinal	  muscular	  atrophy	  (SMA)	  is	  an	  inherited,	  monogenic	  condition,	  resulting	  from	  
homozygous	  deletion	  of	  the	  survival	  of	  motor	  neuron	  (SMN1)	  gene	  1.	  The	  gene	  was	  
originally	  named	  a	  the	  assumption	  that	  it	  is	  specifically	  required	  for	  maintenance	  
and	  survival	  of	  motor	  neurons,	  thereby	  explaining	  the	  primary	  lower	  motor	  neuron-­‐
associated	  phenotypes	  of	  affected	  children.	  In	  addition,	  many	  recent	  studies	  have	  
highlighted	  the	  importance	  of	  SMN	  protein	  for	  the	  normal	  development	  and	  
maintenance	  of	  a	  range	  of	  other	  cell	  types,	  tissues	  and	  organs	  in	  SMA.	  What	  is	  
particularly	  striking,	  is	  the	  discovery	  of	  widespread	  tissue	  and	  organ	  pathology	  
beyond	  the	  neuromuscular	  system	  2,	  3.	  These	  systemic	  pathologies	  may	  manifest	  
sub-­‐clinically	  in	  human	  SMA	  patients	  4,	  5.	  However,	  similar	  defects	  have	  been	  
unmasked	  when	  therapies	  specifically	  targeting	  the	  motor	  system	  resulted	  in	  
significant	  improvement	  of	  motor	  skills,	  but	  failed	  to	  rescue	  overall	  disease	  severity	  
in	  SMA	  mice	  6-­‐8.	  Furthermore,	  recent	  work	  using	  peripherally-­‐targeted	  rescue	  
strategies	  has	  demonstrated	  that	  therapies	  which	  specifically	  do	  not	  modulate	  SMN	  
protein	  levels	  in	  the	  central	  nervous	  system	  (CNS)	  are	  still	  able	  to	  significantly	  
ameliorate	  disease	  severity	  in	  SMA	  mice	  9,	  10.	  
	  
The	  role	  that	  the	  cardiovascular	  system,	  and	  blood	  vessels	  in	  particular,	  plays	  in	  SMA	  
pathogenesis	  remains	  unclear.	  However,	  cardiac	  defects	  have	  been	  described	  in	  
SMA	  patients	  as	  well	  as	  animal	  models	  4,	  5,	  11,	  and	  disrupted	  capillary	  networks	  are	  
reported	  in	  skeletal	  muscle	  from	  SMA	  mice	  12.	  Moreover,	  vascular	  defects	  have	  been	  
linked	  to	  the	  pathogenesis	  of	  other	  neurodegenerative	  conditions	  such	  as	  
Alzheimer’s	  disease	  13,	  and	  diseases	  where	  motor	  neurons	  are	  targeted,	  such	  as	  
amyotrophic	  lateral	  sclerosis	  (ALS)	  14.	  Such	  serious	  and	  significant	  defects	  in	  the	  
capillary	  bed	  are	  likely	  to	  impact	  upon	  the	  delivery	  of	  oxygen	  to	  tissues,	  and	  
potentially	  also	  to	  the	  development	  and	  function	  of	  myriad	  systems	  in	  the	  body.	  
Whether	  damage	  to	  the	  vasculature	  and	  microcirculation	  within	  the	  spinal	  cord	  
occurs	  in	  SMA	  remains	  unknown.	  Here,	  we	  combined	  analysis	  of	  established	  mouse	  
models	  of	  severe	  forms	  of	  SMA	  with	  muscle	  biopsies	  from	  severe	  SMA	  patients	  to	  
address	  these	  questions.	   	  
Materials	  and	  Methods	  
Mice:	  ‘Taiwanese’	  SMA	  mice	  (Jackson	  Labs	  strain	  no.	  005058)	  on	  a	  congenic	  FVB	  
background	  were	  maintained	  as	  breeding	  pairs	  (Smn+/-­‐	  x	  Smn-­‐/-­‐;SMN2tg/tg)	  pairs	  
under	  standard	  SPF	  conditions	  in	  animal	  care	  facilities	  in	  Edinburgh.	  Offspring	  were	  
either	  homozygous	  knockout	  for	  endogenous	  Smn	  (Smn-­‐/-­‐;SMN2tg/0),	  referred	  to	  as	  
SMA	  or	  heterozygous	  for	  Smn	  knockout	  (Smn+/-­‐;SMN2tg/0),	  referred	  to	  as	  
‘Control’.	  	  SMA	  mice	  therefore	  carry	  two	  SMN2	  copies	  on	  one	  allele	  on	  a	  null	  murine	  
Smn	  background	  15.	  Retrospective	  genotyping	  for	  this	  strain	  was	  carried	  out	  using	  
standard	  PCR	  protocols	  16.	  	  
‘Delta	  7’	  SMA	  mice	  on	  a	  congenic	  FVB	  background	  were	  maintained	  as	  heterozygous	  
SMN2+/+;SMN2Δ7+/+;Smn+/-­‐	  (Jackson	  labs	  strain	  no.	  005025)	  breeding	  pairs.	  
Offspring	  were	  either;	  Smn	  KO:	  SMN2+/+;SMNΔ7+/+;Smn−/−,	  referred	  to	  as	  ‘SMA’	  or	  
Smn	  heterozygous;	  SMN2+/+;SMNΔ7+/+;Smn+/−,	  referred	  to	  as	  ‘Control’.	  Some	  
offspring	  are	  homozygous	  wild-­‐type	  for	  Smn	  and	  were	  not	  used	  in	  the	  study.	  Mice	  
were	  maintained	  in	  animal	  care	  facilities	  and	  genotyped	  in	  Oxford	  as	  previously	  
reported	  17.	  In	  each	  case	  the	  morning	  of	  the	  day	  on	  which	  a	  litter	  was	  found	  was	  
designated	  P0.	  All	  animal	  procedures	  and	  breeding	  were	  performed	  under	  licensed	  
authority	  of	  the	  UK	  Home	  Office,	  and	  in	  accordance	  with	  local	  institutional	  
guidelines.	  
Taiwanese	  SMA-­‐affected	  mice	  are	  first	  distinguishable	  from	  control	  littermates	  at	  
P6/7	  by	  reduction	  in	  weight	  and	  early	  weakness.	  They	  are	  typically	  sacrificed	  at	  the	  
humane	  endpoint	  of	  P10-­‐11	  due	  to	  severe	  paralysis.	  Delta	  7	  SMA-­‐affected	  mice	  are	  
first	  distinguishable	  from	  control	  littermates	  at	  P7	  by	  reduction	  in	  weight	  and	  early	  
weakness.	  They	  are	  typically	  sacrificed	  at	  the	  humane	  endpoint	  of	  P13-­‐15	  due	  to	  
severe	  paralysis.	  
Mouse	  tissue	  collection:	  Male	  and	  female	  offspring	  were	  utilised	  in	  this	  study,	  as	  
preliminary	  work	  indicated	  no	  differences	  between	  the	  sexes.	  All	  mice	  were	  
sacrificed	  by	  intraperitoneal	  injection	  of	  sodium	  pentobarbital.	  Whole	  spinal	  cord-­‐
containing	  vertebral	  columns	  and	  proximal	  forelimbs	  were	  rapidly	  dissected	  and	  
fixed	  in	  0.1M	  phosphate	  buffered	  saline	  (PBS)	  containing	  4%	  paraformaldehyde.	  
Tissue	  was	  cryoprotected	  in	  a	  50:50	  solution	  of	  OCT	  and	  30%	  sucrose	  prior	  to	  
freezing	  on	  dry	  ice.	  Sections	  were	  cut	  at	  10	  µm	  from	  the	  proximal	  forelimbs	  
(shoulder	  to	  elbow)	  and	  thoracic	  vertebral	  column	  at	  14µm	  on	  a	  cryostat	  (3080	  
LeicaCM).	  Sections	  were	  selected	  at	  regular	  intervals	  from	  each	  for	  
immunohistochemical	  analysis.	  
	  
SMA	  patient	  and	  control	  individual	  skeletal	  muscle	  biopsies:	  	  
Studies	  on	  muscle	  biopsies	  from	  SMA	  patients	  (age	  range	  1-­‐34	  months	  old,	  n=7)	  and	  
control	  patients	  (age	  range	  0.3-­‐36	  months	  old,	  n=9)	  were	  approved	  by	  the	  NRES	  
Committee	  East	  of	  England	  Institutional	  Ethical	  Committee	  and	  conducted	  under	  
the	  Declaration	  of	  Helsinki.	  Patients’	  personal	  information	  was	  encoded	  to	  protect	  
their	  identity,	  and	  written	  informed	  consent	  obtained	  by	  the	  patient	  or	  the	  
responsible	  guardian.	  All	  patients	  presented	  in	  this	  study	  have	  a	  clear	  clinical	  and	  
pathological	  diagnosis	  of	  SMA	  (data	  not	  shown).	  Control	  muscle	  biopsies	  were	  from	  
individuals	  with	  no	  neuromuscular	  or	  vascular	  diseases.	  	  
	  
Patient	  biopsy	  immunohistochemistry	  
Cryosections	  from	  muscle	  biopsies	  were	  cut	  at	  a	  thickness	  of	  7	  μm	  for	  
immunohistochemistry.	  Muscle	  fibres	  were	  stained	  with	  rabbit	  polyclonal	  anti-­‐
Laminin	  primary	  antibody	  (Sigma	  L9393:	  1:200)	  and	  blood	  vessels	  in	  muscle	  biopsies	  
were	  stained	  with	  mouse	  monoclonal	  anti-­‐CD31/	  PECAM-­‐1	  primary	  antibody	  
(SeroTec	  MCA1738:	  1:100).	  Double	  staining	  of	  Laminin	  and	  CD31/	  PECAM-­‐1	  was	  
visualized	  with	  Alexa	  Fluor	  488	  goat	  anti-­‐Rabbit	  IgG	  (H+L)	  and	  Alexa	  Fluor	  594	  goat	  
anti-­‐Mouse	  IgG	  (H+L)	  (Life	  Technologies:	  1:500).	  Sections	  were	  mounted	  in	  
Hydromount	  mounting	  medium	  (National	  Diagnostics,	  England).	  Images	  were	  
digitally	  captured	  using	  Metamorph	  software.	  	  	  
	  
Mouse	  immunohistochemistry:	  Muscle	  sections	  from	  throughout	  the	  proximal	  
forelimb	  were	  stained	  with	  Rhodamine-­‐labelled	  Griffonia	  simplicifolia	  Lectin-­‐1	  (GSL-­‐
1:	  Vector	  Laboratories	  RL-­‐1102:	  1:100)	  to	  label	  the	  capillary	  bed.	  Some	  sections	  were	  
double	  labeled	  with	  rabbit	  polyclonal	  anti-­‐alpha	  smooth	  muscle	  Actin	  primary	  
antibody	  (a-­‐SMActin:	  abcam	  ab5694:	  1:250),	  visualized	  with	  fluorescein-­‐labelled	  
polyclonal	  swine	  anti-­‐rabbit	  immunoglobulin	  (Jackson	  ImmunoResearch	  Laboratories	  
Inc.:	  1:40)	  to	  stain	  smooth	  muscle	  and	  mounted	  in	  Mowiol.	  
Spinal	  cord	  sections	  were	  stained	  with	  goat	  anti-­‐mouse	  PECAM-­‐1	  primary	  antibody	  
(R&D	  Systems	  AF3628	  at	  1:750).	  After	  washing,	  slides	  were	  incubated	  with	  donkey	  
anti-­‐goat	  Cy3-­‐conjugated	  secondary	  antibody	  (Jackson	  ImmunoResearch	  
Laboratories	  Inc.	  at	  1:250).	  After	  PECAM-­‐1	  staining,	  some	  slides	  were	  incubated	  
overnight	  in	  SMI-­‐32	  primary	  antibody	  (a	  gift	  from	  Professor	  Siddharthan	  Chandran,	  
University	  of	  Edinburgh)	  at	  1:500	  and	  visualized	  with	  donkey	  anti-­‐mouse	  Alexafluor	  
488-­‐conjugated	  secondary	  antibody	  (Dako)	  at	  1:250.	  Slides	  were	  then	  washed	  and	  
mounted	  as	  above.	  	  
Additional	  spinal	  cord	  sections	  were	  stained	  with,	  either	  rabbit	  anti-­‐mouse	  
aquaporin-­‐4	  (AQ-­‐4:	  Abcam	  ab125049),	  rabbit	  anti-­‐mouse	  claudin-­‐5	  (CL-­‐5:	  Abcam	  
ab59720)	  or	  rabbit	  anti-­‐mouse	  zona	  occludens-­‐1	  (ZO-­‐1:	  Abcam	  ab53765)	  primary	  
antibodies,	  all	  at	  a	  concentration	  of	  1:100.	  Each	  was	  visualized	  with	  a	  swine	  anti-­‐
rabbit	  FITC-­‐conjugated	  secondary	  antibody	  (Dako:	  1:40).	  Following	  this,	  capillaries	  
were	  labeled	  with	  GSL-­‐1,	  as	  described	  above.	  	  
Labeling	  of	  hypoxic	  tissue	  with	  pimonidazole	  hydrochloride	  
Entire	   litters	   of	   P5	   Taiwanese	   severe	   model	   SMA	   mice	   were	   injected	   with	   the	  
hypoxia	   marker	   pimonidazole	   hydrochloride	   (PIMO).	   PIMO	   diffuses	   effectively	   in	  
tissue	   including	   the	   CNS	   18,	   is	   retained	   in	   hypoxic	   cells,	   and	   can	   be	   labeled	   with	  
antibodies	  to	  mark	  neurons	  in	  experimental	  hypoxia	  19.	  
A	  single	  60mg/kg	  dose	  of	  PIMO	  was	  administered	  via	   intraperitoneal	   (IP)	   injection.	  
After	   injection	  mice	  were	  returned	  to	  their	  cage	  with	  their	  parents	  for	  1	  hr,	  during	  
which	   time	   the	   mice	   were	   closely	   monitored.	   In	   this	   hour,	   PIMO	   was	   delivered	  
systemically	  to	  all	  body	  tissues	  via	  the	  bloodstream.	  In	  mice,	  PIMO	  has	  a	  plasma	  half-­‐
life	  of	  ~25	  min	  20,	  and	  is	  cleared	  by	  the	  kidneys	  18.	  Thus,	  experimental	  durations	  of	  an	  
hour	  or	  longer	  between	  injection	  and	  sacrifice	  allow	  for	  the	  systemic	  distribution	  of	  
PIMO	  and	   its	   subsequent	   clearance	   from	   the	  plasma.	  90	  min	  after	  PIMO	   injection,	  
Taiwanese	   SMA	   mice	   and	   control	   littermates	   were	   sacrificed	   by	   an	   overdose	   of	  
anaesthetic	   administered	   via	   IP	   injection	  of	   sodium	  pentabarbitol	   (Euthenal).	  Mice	  
were	   sacrificed	   in	   the	   order	   they	  were	   initially	   injected	  with	   PIMO.	   Each	   injection	  
was	  timed	  to	  ensure	  that	  each	  animal	  was	  exposed	  to	  PIMO	  for	  an	  equal	  amount	  of	  
time	  and	  given	  the	  same	  time	  to	  clear	  residual	  unbound	  PIMO	  from	  the	  plasma.	  At	  
the	  time	  of	  tissue	  collection,	  PIMO	  will	  already	  be	  bound	  to	  proteins	  in	  any	  hypoxic	  
cells	  in	  the	  body	  tissues.	  During	  harvesting,	  tissue	  becomes	  anoxic,	  but	  the	  very	  low	  
levels	  of	  PIMO	  remaining	  in	  the	  plasma	  at	  the	  time	  of	  collection	  should	  prevent	  any	  
PIMO	  binding	  as	  a	  result	  of	  dissection	  anoxia.	  To	  further	  ensure	  this,	  dissections	  of	  
spinal	  cord	  were	  performed	  rapidly	  with	  tissues	  being	  collected	  and	  fixed	  in	  <5	  min.	  
Nissl	  co-­‐staining	  was	  also	  carried	  out	  on	  sections,	  to	  identify	  grey	  and	  white	  matter	  
regions	  of	  the	  spinal	  cord,	  using	  a	  0.2%	  solution	  of	  cresyl	  fast	  violet	  (CFV).	  
	  
Imaging	  and	  Quantification	  	  
All	  images	  were	  captured	  using	  a	  chilled	  CCD	  camera	  (Hammamatsu	  C4742-­‐95)	  using	  
OpenLab	  image	  capture	  software	  on	  an	  Olympus	  IX71	  microscope.	  
Muscle	  capillary	  density	  (mouse):	  was	  calculated	  for	  the	  group	  of	  muscles	  visible	  in	  
sections	  through	  the	  proximal	  forelimb;	  for	  each	  muscle,	  six	  images	  at	  x20	  
magnification	  were	  collected.	  Over	  1000	  evenly	  distributed	  images	  were	  captured	  
from	  the	  centre	  and	  at	  90o,	  180o	  and	  270o	  to	  a	  vertical	  line	  drawn	  through	  the	  centre	  
of	  the	  muscle	  toward	  the	  periphery.	  Capillary	  density	  as	  a	  percentage	  of	  muscle	  area	  
was	  calculated	  12.	  The	  same	  images	  were	  used	  to	  calculate	  the	  ratio	  of	  capillaries	  to	  
muscle	  fibers	  (C:F),	  from	  counts	  of	  the	  numbers	  of	  muscle	  fiber	  and	  capillary	  profiles	  
wholly	  present	  in	  each	  image.	  	  
Intramuscular	  arterioles:	  were	  analysed	  in	  vessels	  that	  expressed	  α-­‐SMActin;	  the	  
diameters	  of	  both	  the	  vessel	  and	  the	  smooth	  muscle,	  standardised	  to	  a	  circle,	  were	  
calculated	  using	  the	  formula:	  𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟(µμ𝑚) = 2(√!"#!(!!)! ).	  A	  ratio	  of	  vessel	  
diameter/smooth	  muscle	  diameter	  (v/m)	  then	  generated	  an	  arbitrary	  value	  for	  each	  
vessel	  representing	  the	  thickness	  of	  the	  outer	  layer	  of	  smooth	  muscle	  relative	  to	  the	  
vessel	  diameter.	  
Spinal	  cord	  capillary	  density:	  was	  calculated	  from	  three	  sections	  per	  slide	  from	  a	  
minimum	  of	  three	  slides	  for	  each	  mouse.	  Spinal	  cords	  were	  divided	  into	  
dorsal/ventral	  and	  left/right,	  and	  adjacent	  CFV-­‐stained	  slides	  used	  to	  segment	  white	  
and	  grey	  matter.	  Within	  each	  quadrant,	  three	  radial	  lines	  of	  40x	  images,	  originating	  
from	  the	  central	  canal	  and	  extending	  to	  the	  edge	  of	  the	  cord,	  were	  captured.	  The	  
percentage	  vessel	  area	  was	  then	  calculated	  as	  for	  skeletal	  muscle,	  and	  blind	  to	  
genotype.	  	  
Tissue	  hypoxia:	  was	  analysed	  by	  counting	  cells	  double-­‐labeled	  for	  CFV	  (a	  neuronal	  
marker)	  and	  DAB	  (a	  marker	  of	  hypoxia)	  in	  spinal	  cord	  ventral	  horn	  and	  by	  calculating	  
the	  proportion	  of	  DAB	  (hypoxic)	  stained	  tissue	  in	  sections	  of	  skeletal	  muscle.	  	  
Muscle	  capillary	  density	  (human):	  was	  analysed	  from	  3-­‐9	  (mean=5)	  non-­‐consecutive	  
sections	  per	  muscle	  biopsy,	  which	  were	  photographed	  at	  x40	  magnification	  and	  
quantified	  to	  calculate	  C:F	  ratio	  as	  indicated	  above	  for	  mouse.	  
Statistical	  analysis:	  All	  data	  were	  collected	  using	  Microsoft	  Excel	  software.	  Graphs	  
were	  generated	  and	  statistical	  analyses	  performed	  using	  GraphPad	  Prism	  software.	  
Bar	  charts	  represent	  mean	  ±	  s.e.m.	  and	  scatter	  plots	  show	  data	  points	  and	  mean	  
values.	  Statistical	  significance	  was	  considered	  to	  be	  p<0.05.	  Statistical	  tests	  used	  are	  
detailed	  in	  the	  figure	  legends.	  	   	  
Results	  
Given	  the	  evidence	  for	  pathology	  outside	  the	  nervous	  system	  in	  SMA,	  we	  
investigated	  the	  vascular	  system	  and	  specifically	  the	  capillary	  bed	  of	  clinically-­‐
relevant,	  proximal	  skeletal	  muscles	  and	  spinal	  cord	  in	  mice	  and	  skeletal	  muscle	  
biopsies	  from	  type	  1	  SMA	  patients.	  We	  set	  out	  to	  determine	  if	  blood	  supply	  to	  motor	  
nerve	  terminals	  in	  skeletal	  muscle	  or	  motor	  neuron	  cell	  bodies	  in	  spinal	  cord	  is	  
compromised	  and	  therefore	  potentially	  significant	  in	  the	  aetiology	  of	  SMA.	  	  
	  
Vasculature	  is	  aberrant	  in	  post-­‐natal	  SMA	  proximal	  skeletal	  muscle	  
First,	  we	  extended	  previous	  studies	  detailing	  significant	  defects	  in	  muscle	  capillaries	  
in	  trunk	  muscles12,	  by	  demonstrating	  that	  there	  are	  parallel	  significant	  vascular	  
defects	  in	  clinically-­‐relevant,	  proximal,	  forelimb	  muscles	  at	  a	  symptomatic	  time-­‐point	  
(P8)	  in	  the	  Taiwanese	  mouse	  model	  of	  severe	  SMA.	  	  
A	  marked	  decrease	  in	  the	  density	  of	  intra-­‐muscular	  capillaries	  (GSL-­‐1	  staining)	  was	  
immediately	  apparent	  in	  transverse	  sections	  of	  multiple,	  individual	  skeletal	  muscles	  
from	  proximal	  forelimbs	  in	  SMA	  mice	  (Fig	  1A,B)	  compared	  with	  control	  littermates.	  
As	  a	  percentage	  of	  cross	  sectional	  area,	  muscle	  from	  SMA	  mice	  was	  less	  than	  half	  as	  
capillary-­‐dense	  as	  control	  littermates	  (Fig	  1C).	  Closer	  observation	  showed	  that	  many	  
muscle	  fibers	  were	  no	  longer	  adjacent	  to	  capillaries	  in	  SMA	  muscles	  (Fig	  1B).	  
Therefore	  we	  next	  calculated	  the	  number	  of	  capillary	  profiles	  per	  muscle	  fiber	  
profile,	  which	  is	  perhaps	  a	  more	  informative	  functional	  measure	  of	  perfusion	  
distances	  and	  controls	  for	  bias	  introduced	  by	  variations	  in	  muscle	  fiber	  diameter,	  as	  
occur	  in	  neuromuscular	  wasting	  diseases	  such	  as	  SMA.	  The	  capillary/muscle	  fiber	  
ratio	  in	  SMA	  mice	  was	  only	  40%	  of	  that	  in	  control	  littermates	  (Fig	  1D),	  confirming	  
skeletal	  muscle	  hypovascularity	  in	  SMA.	  Larger	  arterioles,	  identified	  as	  α-­‐Smooth	  
Muscle	  Actin-­‐(α	  –SMA)	  expressing	  vessels,	  appeared	  morphologically	  normal	  and	  
mature	  We	  then	  checked	  if	  these	  intra-­‐muscular	  arterioles	  were	  structurally	  normal	  
and	  the	  mean	  caliber	  of	  intramuscular	  arterioles	  was	  not	  significantly	  different	  
between	  SMA:	  1.90µm	  and	  littermate	  control:	  1.64µm	  mice,	  (NS	  P>0.05	  unpaired,	  
two-­‐tailed	  t-­‐test)	  and	  mature,	  as	  the	  ratio	  of	  vessel	  caliber	  (v)	  to	  the	  surrounding	  
smooth	  muscle	  diameter	  (m)	  v/m	  was	  not	  significantly	  different	  between	  SMA:	  
0.738	  and	  control	  littermate:	  0.753	  mice,	  (NS	  P>0.05	  unpaired,	  two-­‐tailed	  t-­‐test)	  but	  
were	  reduced	  in	  number	  in	  SMA	  mice:	  57%	  compared	  to	  control	  littermates	  (Fig	  1E).	  	  
Thus,	  there	  were	  significantly	  fewer	  capillaries	  (small	  vessels	  including	  arterioles	  and	  
venules)	  and	  fewer	  larger	  and	  mature,	  intramuscular	  arterioles	  in	  clinically-­‐relevant,	  
proximal	  forelimb	  muscles	  in	  Taiwanese	  severe	  SMA	  mice	  at	  a	  symptomatic	  time-­‐
point.	  Therefore,	  diffusion	  distances	  were	  increased	  and	  perfusion	  to	  muscle	  fibers	  
and	  motor	  nerve	  terminals	  was	  likely	  compromised.	  	  
	  
Aberrant	  vasculature	  is	  also	  present	  in	  skeletal	  muscle	  from	  human	  SMA	  patients	  
We	  were	  particularly	  interested	  to	  determine	  if	  similar	  vascular	  changes	  were	  
present	  in	  SMA	  patients.	  To	  this	  end	  skeletal	  muscle	  biopsies	  from	  7	  type	  I/II	  
patients	  and	  9	  controls	  were	  obtained,	  immunostained	  and	  analysed	  in	  an	  identical	  
manner	  to	  the	  mouse	  samples.	  As	  was	  seen	  in	  mouse	  models,	  there	  were	  no	  
differences	  in	  vascularity	  immediately	  after	  birth,	  but	  with	  increasing	  development,	  
dramatic	  discrepancies	  became	  apparent.	  Muscle	  from	  control	  children	  showed	  a	  
steady	  increase	  in	  C:F	  ratio	  from	  0.1:1	  at	  0.5	  months	  to	  0.8:1	  at	  36	  months	  (Fig	  2A,C),	  
which	  approaches	  a	  mature	  ratio	  of	  >1.0:1	  21,	  22.	  In	  contrast,	  biopsies	  from	  Type	  I/II	  
severe	  patients	  showed	  a	  failure	  to	  develop	  beyond	  the	  situation	  at	  birth,	  with	  a	  
ratio	  of	  0.09:1	  at	  1	  month	  and	  0.08:1	  at	  33	  months	  (Fig	  2A,C).	  By	  33/36	  months	  of	  
age	  there	  was	  a	  tenfold	  difference	  in	  capillary:	  fibre	  ratio	  between	  control	  and	  SMA	  
muscle	  biopsies.	  Regression	  analysis	  of	  the	  data	  shows	  a	  clear	  and	  significant	  
diference	  in	  the	  rate	  of	  vascularisation	  between	  control	  and	  SMA	  biopsies	  (Fig	  2C).	  
This	  results	  in	  muscle	  fibres	  being	  much	  more	  distant	  from	  capillaries	  at	  33/36	  
months	  in	  SMA	  compared	  with	  control	  muscles	  (Fig	  2B).	  	  
These	  data	  demonstrate	  comparable	  vascular	  defects,	  and	  in	  particular	  an	  apparent	  
falure	  to	  develop	  significantly	  after	  birth	  in	  severe	  SMA	  patients,	  directly	  analagous	  
to	  those	  described	  in	  severe	  mouse	  models	  of	  SMA.	  	  
	  
Post-­‐natal	  development	  of	  spinal	  cord	  vasculature	  in	  wild-­‐type	  mice	  
We	  next	  turned	  our	  attention	  to	  the	  spinal	  cord,	  in	  order	  to	  establish	  whether	  the	  
loss	  of	  motor	  neuron	  cell	  bodies	  that	  occurs	  in	  SMA	  also	  correlates	  with	  vascular	  
changes.	  Surprisingly,	  post-­‐natal	  development	  of	  spinal	  cord	  vasculature	  in	  the	  
mouse	  has	  not	  been	  consistently	  or	  clearly	  described	  in	  the	  literature.	  Therefore,	  we	  
first	  established	  the	  normal	  parameters	  for	  capillary	  development	  in	  the	  post-­‐natal	  
spinal	  cord	  of	  wild-­‐type	  C57Bl	  mice	  to	  establish	  baseline	  data.	  In	  very	  young	  animals	  
and	  as	  a	  percentage	  of	  spinal	  cord	  cross-­‐sectional	  area,	  capillaries	  were	  sparse	  (P3),	  
but	  progressively	  increased	  in	  density	  (Fig	  3A)	  and	  caliber	  (Fig	  3B)	  during	  the	  first	  3	  
weeks	  of	  post-­‐natal	  development.	  Capillary	  density	  in	  the	  grey	  and	  white	  matter	  was	  
similar	  at	  P3,	  began	  to	  increase	  in	  grey	  matter	  at	  P7,	  was	  significantly	  greater	  by	  P14,	  
and	  was	  more	  than	  double	  that	  in	  white	  matter	  by	  P21	  (Fig	  3C).	  Over	  this	  3	  week	  
period,	  capillary	  density	  had	  doubled	  in	  white	  matter	  and	  quadrupled	  in	  grey	  matter.	  	  
In	  summary,	  capillaries	  were	  initially	  sparse	  in	  the	  early	  post-­‐natal	  mouse	  spinal	  
cord,	  but	  equally	  distributed	  throughout	  grey	  and	  white	  matter	  regions.	  There	  was	  a	  
subsequent	  significant	  increase	  in	  both	  the	  size	  and	  ramification	  of	  capillaries	  during	  
the	  first	  3	  weeks	  of	  post-­‐natal	  development,	  superseding	  the	  growth	  of	  the	  spinal	  
cord,	  and	  was	  most	  notable	  in	  grey	  matter	  (where	  motor	  neuron	  cell	  bodies	  are	  
located).	  	  
	  
Capillary	  density	  in	  spinal	  cord	  is	  dramatically	  decreased	  in	  Taiwanese	  SMA	  mice	  
When	  we	  repeated	  the	  analyses	  of	  spinal	  cord	  vasculature	  on	  litters	  of	  Taiwanese	  
SMA	  mice,	  it	  was	  immediately	  apparent,	  from	  images	  of	  stained	  capillaries	  in	  whole	  
spinal	  cord,	  that	  there	  was	  a	  marked	  decrease	  in	  capillary	  density	  in	  SMA	  compared	  
to	  control	  littermates	  at	  P11.	  At	  this	  late	  symptomatic	  stage,	  capillaries	  were	  still	  
sparse	  in	  the	  spinal	  cord	  of	  SMA	  mice,	  leaving	  considerable	  distances	  between	  
neighboring	  vessels.	  Little	  of	  the	  expected	  differentiation	  between	  white	  and	  grey	  
matter	  was	  apparent	  in	  SMA	  mice	  compared	  to	  that	  observed	  in	  littermate	  control	  
mouse	  spinal	  cords	  (Fig	  4A,B),	  including	  the	  ventral	  grey	  horn.	  This	  finding	  suggested	  
that	  capillary	  density	  had	  not	  significantly	  increased	  in	  the	  region	  of	  spinal	  cord	  
containing	  lower	  motor	  neuron	  cell	  bodies	  over	  this	  period	  in	  SMA.	  A	  subsequent	  
temporal	  analysis	  revealed	  that	  capillaries	  were	  equally	  sparse	  in	  both	  SMA	  and	  
control	  mouse	  spinal	  cords	  at	  birth,	  and	  had	  not	  increased	  in	  SMA	  by	  P5,	  resulting	  in	  
a	  significantly	  hypovascular	  appearance	  (Fig	  4C).	  By	  P11,	  SMA	  spinal	  cords	  were	  less	  
than	  half	  as	  capillary-­‐dense	  as	  control	  littermates	  (Fig	  4C),	  with	  segmentation	  of	  
dorsal	  and	  ventral	  grey	  and	  white	  matter	  revealing	  that	  all	  territories	  of	  the	  spinal	  
cord	  were	  similarly	  depleted	  (Fig	  4D-­‐G).	  	  
In	  summary,	  capillary	  density	  did	  not	  increase	  in	  SMA	  mouse	  spinal	  cord	  between	  P3	  
(pre-­‐symptomatic)	  and	  P11	  (late-­‐symptomatic)	  stages.	  Capillary	  growth	  in	  mouse	  
spinal	  cord	  occurs	  by	  sprouting	  angiogenesis,	  suggesting	  a	  defect	  in	  this	  process	  
when	  SMN	  levels	  are	  reduced.	  Such	  post-­‐natal	  developmental	  hypovascularity	  would	  
likely	  lead	  to	  increased	  diffusion	  distances	  between	  capillaries	  and	  motor	  neurons	  in	  
the	  ventral	  grey	  horn.	  	  
	  
Significant	  vascular	  deficiency	  of	  spinal	  cord	  is	  replicated	  in	  a	  second	  mouse	  model	  of	  
severe	  SMA	  
We	  were	  keen	  to	  determine	  if	  these	  significant	  vascular	  defects	  were	  epiphenomena	  
specific	  to	  SMN	  gene	  manipulation	  in	  the	  Taiwanese	  SMA	  model	  mouse,	  or	  rather	  
represented	  a	  common	  feature	  of	  neuromuscular	  pathology	  in	  mouse	  models	  of	  
severe	  SMA.	  Therefore,	  we	  turned	  to	  another	  commonly	  used	  and	  well	  
characterized	  mouse	  model	  of	  SMA	  (Δ7	  mice	  23).	  We	  chose	  P14	  as	  a	  direct	  
comparison	  with	  the	  P11	  data	  from	  the	  Taiwanese	  model,	  representing	  a	  late	  
symptomatic	  time-­‐point	  3,	  24-­‐26.	  In	  these	  slightly	  older	  mice	  the	  differential	  capillary	  
density	  between	  grey	  and	  white	  matter	  is	  more	  apparent	  in	  both	  control	  and	  SMA	  
spinal	  cords.	  Capillary	  density	  was	  quantified	  in	  an	  identical	  manner,	  and	  significant	  
decreases	  were	  seen	  in	  each	  region	  and	  territory	  of	  the	  spinal	  cord	  in	  SMA	  
compared	  to	  littermate	  controls	  (data	  not	  shown).	  Pooling	  the	  data	  for	  all	  regions,	  
for	  this	  second	  mouse	  model	  of	  severe	  SMA,	  we	  found	  the	  same	  pronounced	  and	  
significant	  decrease	  in	  capillary	  density	  in	  SMA	  spinal	  cord	  (Fig	  4H-­‐J).	  In	  fact	  the	  
relative	  capillary	  density	  in	  P14	  Δ7	  mice	  is	  remarkably	  similar	  to	  that	  in	  the	  younger	  
P11	  Taiwanese	  mice.	  In	  each	  case	  this	  density	  appears	  to	  have	  been	  maintained	  and	  
to	  not	  have	  increased	  since	  the	  early	  post-­‐natal	  period.	  
Taken	  together,	  these	  data	  suggest	  that	  a	  pronounced	  post-­‐natal,	  developmental	  
capillary	  deficiency	  is	  a	  robust	  and	  repeatable	  consequence	  of	  SMN	  depletion	  in	  
mouse	  spinal	  cord.	  When	  considered	  alongside	  the	  reproducible	  capillary	  defects	  
observed	  in	  skeletal	  muscle,	  we	  suggest	  that	  SMN	  depletion	  leads	  to	  widespread	  
defects	  in	  post-­‐natal	  angiogenesis.	  Significantly,	  these	  two	  affected	  tissues	  
encompass	  both	  the	  somatic	  and	  synaptic	  (neuromuscular	  junction)	  fields	  of	  lower	  
motor	  neurons.	  
	  
Depleted	  vasculature	  results	  in	  significant	  in	  vivo	  hypoxia	  in	  spinal	  cord	  of	  severe	  
Taiwanese	  SMA	  mice	  
The	  sparse	  capillary	  bed	  observed	  in	  SMA	  spinal	  cord	  resulted	  in	  increased	  diffusion	  
distances	  between	  motor	  neurons	  and	  their	  capillaries	  (Fig5	  A).	  A	  key	  question	  to	  
address	  was	  whether	  this	  vascular	  phenotype	  had	  any	  impact	  upon	  the	  
oxygenation/hypoxia	  status	  of	  lower	  motor	  neuron	  cell	  bodies	  in	  SMA.	  In	  order	  to	  
test	  this	  we	  used	  a	  technique	  where	  hypoxic	  cells	  can	  be	  tagged	  in	  vivo	  and	  later	  
identified	  after	  sacrifice	  using	  pimonidazole	  hydrochloride	  (PIMO).	  PIMO	  binds	  to	  
thiol	  residues	  in	  cells	  with	  an	  oxygen	  concentration	  less	  than	  14	  µM	  which	  is	  
equivalent	  to	  an	  oxygen	  tension	  <10	  mm	  Hg	  at	  37°C	  27.	  Physiological	  oxygen	  tension	  
differs	  depending	  on	  the	  body	  tissue,	  but	  a	  value	  >35	  mm	  Hg	  in	  the	  brain	  is	  
considered	  sufficient	  to	  ensure	  normal	  oxygenation	  28.	  PIMO	  labeling	  therefore	  
indicates	  oxygenation	  levels	  <30%	  that	  in	  the	  healthy	  CNS.	  
P5	  Taiwanese	  severe	  SMA	  mice	  were	  chosen	  for	  PIMO-­‐dosing	  and	  sacrifice,	  as	  it	  
represents	  a	  pre/	  early	  symptomatic	  time-­‐point,	  at	  which	  vascular	  defects	  were	  
present,	  but	  the	  mice	  remained	  generally	  healthy	  (at	  this	  age	  SMA	  mice	  are	  virtually	  
indistinguishable	  from	  their	  healthy	  littermates	  in	  our	  hands).	  We	  double-­‐labeled	  
spinal	  cord	  to	  allow	  parallel	  visualization	  and	  quantification	  of	  Nissl-­‐positive	  neurons	  
and	  DAB-­‐positive	  hypoxic	  cells.	  In	  control,	  non-­‐PIMO	  injected	  staining	  experiments	  
no	  DAB-­‐positive	  (hypoxic)	  cells	  were	  present	  in	  spinal	  cord	  (data	  not	  shown).	  This	  
demonstrated	  both	  the	  efficacy	  of	  the	  technique	  and	  the	  absence	  of	  subsequent	  
false	  positive	  results	  in	  PIMO-­‐dosed	  mice.	  Control	  littermates	  injected	  with	  PIMO	  
showed	  very	  few	  cells	  with	  a	  positive	  PIMO-­‐antibody	  reaction,	  indicating	  very	  little	  
tissue	  hypoxia	  (Fig	  5B).	  However,	  in	  striking	  contrast,	  PIMO-­‐positive	  cells	  were	  
widely	  distributed	  throughout	  the	  spinal	  cord,	  many	  of	  which	  were	  neurons,	  being	  
co-­‐stained	  for	  Nissl	  substance	  (Fig	  5B).	  DAB	  positive	  tissue	  has	  been	  thresholded	  and	  
highlighted	  to	  demonstrate	  areas	  of	  tissue	  hypoxia	  (Fig5	  C).	  Quantification	  of	  DAB	  
and	  Nissl	  co-­‐positive	  large	  neurons	  in	  the	  ventral	  gray	  horn	  (representing	  lower	  
motor	  neurons)	  indicated	  a	  significant	  (>3	  fold)	  increase	  in	  hypoxic	  neurons	  in	  the	  
spinal	  cord	  of	  Taiwanese	  SMA	  mice	  compared	  to	  control	  littermates	  (Fig	  5D).	  	  
In	  summary,	  spinal	  cord,	  and	  in	  particular	  lower	  motor	  neuron	  soma,	  were	  hypoxic	  
at	  early	  symptomatic	  time-­‐points	  in	  severe	  SMA	  mice.	  This	  finding	  demonstrates	  
that	  the	  depleted	  vasculature	  phenotype	  in	  SMA	  mice	  leads	  to	  functional	  hypoxia	  in	  
clinically-­‐relevant	  tissue	  and	  may	  therefore	  provide	  an	  additional	  pathway	  through	  
which	  the	  neuromuscular	  system	  is	  rendered	  vulnerable	  in	  SMA.	  	  
	  
The	  blood-­‐spinal	  cord	  barrier	  is	  defective	  in	  SMA	  mice	  
Hypoxia	  will	  have	  direct	  effects	  upon	  motor	  neurons,	  but	  in	  addition	  may	  result	  in	  
secondary	  changes	  in	  spinal	  cord,	  which	  could	  further	  damage	  motor	  neurons.	  
Hypoxia	  can	  trigger	  changes	  in	  the	  blood	  brain	  barrier	  (BBB)	  29,	  and	  leaky	  BBB	  and	  
blood	  spinal	  cord	  barriers	  (BSCB)	  have	  been	  shown	  to	  lead	  to	  direct	  damage	  of	  
motor	  neurons	  30.	  Therefore	  we	  set	  out	  to	  determine	  if	  the	  BSCB	  showed	  any	  signs	  
of	  damage	  in	  SMA	  spinal	  cord	  31.	  We	  examined	  3	  core	  elements	  of	  the	  BSCB;	  the	  
tight-­‐junctional	  proteins	  claudin-­‐5	  (CL-­‐5)	  and	  zona	  occludens-­‐1	  (ZO-­‐1)	  found	  on	  
endothelial	  cells,	  and	  the	  water	  transporter	  aquaporin-­‐4	  (AQ-­‐4)	  found	  on	  astrocytes.	  
At	  P11,	  ZO-­‐1	  was	  closely	  co-­‐localised	  with	  GSL-­‐1	  positive	  blood	  vessels,	  and	  AQ-­‐4	  
was	  also	  associated	  with	  all	  vessels	  examined	  in	  SMA	  mouse	  spinal	  cord.	  In	  contrast,	  
CL-­‐5	  showed	  a	  very	  heterogeneous	  distribution	  in	  SMA	  mice.	  Here,	  many	  vessels	  
showed	  close	  co-­‐localisation,	  but	  many	  were	  negative	  for	  CL-­‐5	  (Fig	  6).	  Given	  that	  
hypoxia	  is	  known	  to	  affect	  CL-­‐5	  accumulation,	  we	  suggest	  that	  these	  changes	  in	  the	  
BSCB	  occur	  downstream	  of	  spinal	  cord	  hypoxia.	  It	  is	  therefore	  likely,	  that	  an	  
incomplete	  BSCB	  barrier	  will	  further	  amplify	  motor	  neuron	  damage	  in	  SMA.	  
In	  summary	  the	  BSCB	  was	  impaired	  in	  SMA	  mouse	  spinal	  cord,	  thereby	  identifying	  an	  
additional,	  indirect	  and	  negative	  consequence	  of	  abnormal	  vascular	  development,	  
that	  could	  contribute	  directly	  to	  motor	  neuron	  pathology	  in	  SMA.	   	  
Discussion	  
	  
We	  can	  no	  longer	  view	  SMA	  as	  a	  disease	  that	  solely	  and	  specifically	  affects	  
‘vulnerable’	  motor	  neurons.	  	  Evidence	  now	  points	  to	  significant	  systemic	  defects	  in	  
SMA,	  but	  as	  both	  motor	  neurons	  and	  skeletal	  muscles	  are	  early	  and	  key	  targets	  of	  
SMA,	  we	  need	  to	  better	  understand	  how	  SMN-­‐depletion	  within	  these	  cell	  types	  can	  
impact	  on	  the	  development	  and	  survival	  of	  the	  neuromuscular	  system.	  
This	  study	  has	  revealed	  significant	  defects	  in	  the	  development	  and	  post-­‐natal	  
maturation	  of	  capillary	  beds	  in	  SMA	  disease-­‐relevant,	  proximal	  skeletal	  muscle	  and	  
spinal	  cord	  in	  the	  first	  couple	  of	  post-­‐natal	  weeks	  in	  severe	  SMA	  mice.	  Importantly,	  
we	  show	  that	  similar	  vascular	  defects	  are	  also	  present	  in	  severe	  SMA	  patient	  muscle	  
biopsies.	  Significantly,	  we	  build	  on	  these	  findings	  to	  demonstrate	  that	  vascular	  
defects	  in	  SMA	  lead	  to	  in	  vivo	  hypoxia	  of	  spinal	  cord	  (including	  lower	  motor	  neuron	  
soma)	  at	  an	  early	  symptomatic	  time-­‐point.	  In	  addition	  to	  the	  gross	  defects	  in	  
vascular	  development,	  defects	  in	  key	  BSCB	  proteins	  are	  also	  present	  in	  SMA	  mouse	  
spinal	  cord.	  Given	  the	  known	  sensitivity	  of	  lower	  motor	  neurons	  to	  hypoxia	  in	  vivo	  32,	  
these	  findings	  highlight	  a	  novel	  link	  between	  systemic	  vascular	  pathology	  and	  the	  
particular	  vulnerability	  of	  the	  neuromuscular	  system	  in	  SMA.	  This	  novel	  description	  
of	  vascular	  defects	  in	  severe	  forms	  of	  SMA,	  suggests	  that	  therapeutic	  targeting	  of	  
the	  vascular	  system	  in	  order	  to	  ameliorate	  functional	  hypoxia	  and	  BSCB	  defects	  is	  
likely	  to	  be	  required	  in	  order	  to	  deliver	  a	  systemic	  rescue	  of	  SMA.	  	  
	  
Skeletal	  muscle	  capillary	  beds	  fail	  to	  develop	  normally	  in	  the	  early	  post-­‐natal	  period	  
In	  SMA	  proximal	  skeletal	  muscle,	  capillary	  density,	  calculated	  using	  either	  a	  measure	  
of	  capillary	  density	  per	  unit	  area	  or	  number	  of	  capillaries	  per	  muscle	  fiber	  profile,	  
was	  less	  than	  half	  that	  in	  control	  littermates	  (Fig	  1C,D).	  Diffusion	  distances	  were	  
therefore	  increased	  and	  many	  individual	  fibers	  were	  no	  longer	  immediately	  adjacent	  
to	  a	  capillary	  (Fig	  1B).	  The	  number	  of	  small,	  presumed	  angiogenic,	  capillaries	  was	  
most	  severely	  affected,	  but	  larger,	  intramuscular	  arterioles	  expressing	  α-­‐SMActin	  
appeared	  to	  some	  extent	  spared	  in	  skeletal	  muscle	  (Fig	  1E).	  We	  have	  previously	  
shown	  that	  skeletal	  muscle	  capillary	  beds	  appear	  normal	  at	  birth	  12,	  suggesting	  that	  
vessels	  present	  at	  birth	  remain,	  mature	  normally,	  and	  are	  largely	  unaffected	  by	  
disease	  progression,	  but	  that	  small	  vessels	  undergoing	  active	  angiogenesis	  as	  the	  
animal	  grows,	  are	  most	  affected.	  Most	  importantly,	  the	  capillary	  bed	  is	  severely	  
compromised	  and	  diffusion	  distances	  to	  both	  muscle	  fibers	  and	  nerve	  terminals	  at	  
neuromuscular	  junctions	  are	  increased.	  We	  have	  previously	  shown	  that	  neonatal	  
mouse	  neuromuscular	  junctions	  are	  surprisingly	  resistant	  to	  hypoxic	  injury,	  but	  this	  
resistance	  is	  rapidly	  lost	  after	  P10,	  leaving	  P21	  mice	  very	  sensitive	  to	  even	  relatively	  
short	  periods	  of	  hypoxic	  insult	  33.	  Further,	  hypoxia-­‐reperfusion	  injury	  as	  occurs	  when	  
the	  quality	  of	  tissue	  perfusion	  oscillates	  produces	  profound	  injury	  to	  motor	  nerve	  
terminals	  while	  leaving	  skeletal	  muscle	  fibers	  relatively	  unscathed	  34.	  The	  
pathological	  presentation	  of	  these	  injuries	  is	  not	  dissimilar	  from	  the	  motor	  nerve	  
terminal	  damage	  seen	  as	  one	  of	  the	  earliest	  pathological	  features	  in	  SMA	  16.	  A	  very	  
recent	  report	  has	  shown	  that	  post-­‐natal	  hypoxia	  significantly	  stunts	  growth	  and	  
negatively	  modulates	  motor	  function	  35. Taken together, these studies point	  toward	  
possible	  disease	  mechanisms.	   
	  
Conserved	  vascular	  defects	  are	  present	  in	  human	  severe	  SMA	  patients	  and	  mouse	  
models	  of	  severe	  SMA	  
We	  were	  keen	  to	  determine	  whether	  the	  data	  from	  the	  two	  mouse	  models	  of	  severe	  
SMA	  accurately	  predicted	  vascular	  defects	  in	  SMA	  patients.	  Type	  I/II	  patient	  skeletal	  
muscle	  biopsies	  showed	  muscle	  atrophy	  as	  expected	  (Fig	  2B)	  36,	  and	  given	  these	  
differences	  in	  fiber	  size,	  the	  calculation	  of	  capillary:	  fibre	  ratio,	  as	  used	  here,	  is	  the	  
most	  reliable	  indicator	  of	  overall	  muscle	  vascularity.	  This	  methodology	  indicated	  
similar	  values	  at	  under	  1	  month	  of	  age	  (C:F	  =	  0.1:1	  in	  Control	  and	  0.08:1	  in	  SMA),	  but	  
a	  tenfold	  difference	  in	  values	  at	  33-­‐36	  months	  of	  age	  (C:F	  =	  0.8:1	  in	  Control	  and	  
0.08:1	  in	  SMA).	  These	  data	  suggest	  that	  capillary	  beds	  are	  relatively	  normal	  at	  birth,	  
but	  then	  fail	  to	  develop	  as	  the	  child	  grows,	  which	  exactly	  mirrors	  the	  data	  collected	  
from	  the	  two	  mouse	  models	  of	  severe	  SMA,	  suggestive	  of	  a	  disruption	  of	  post-­‐natal	  
angiogenesis	  in	  SMA.	  This	  supports	  the	  concept	  of	  ‘threshold	  pathology’	  in	  SMA,	  and	  
the	  notion	  that	  therapies	  directed	  solely	  at	  the	  nervous	  system,	  may	  ultimately	  
uncover	  additional	  non-­‐neuronal	  pathologies	  3.	  This	  also	  further	  argues	  for	  the	  
importance	  of	  systemic	  treatment	  approaches,	  particularly	  in	  severe	  SMA,	  as	  
suggested	  by	  recent	  SMN	  viral	  delivery	  and	  oligonucleotide	  studies	  9,	  10.	  Taken	  
together,	  these	  data	  provide	  support	  for	  the	  idea	  that	  severe	  SMA	  mice	  are	  reliable	  
models	  in	  which	  to	  study	  both	  the	  development	  and	  treatment	  of	  significant,	  
vascular	  pathology	  in	  severe	  SMA	  patients.	  
	  
Spinal	  cord	  capillary	  beds	  fail	  to	  develop	  normally	  in	  the	  early	  post-­‐natal	  period	  
The	  pathological	  hallmark	  of	  SMA	  is	  the	  profound	  loss	  of	  spinal	  motor	  neurons.	  With	  
this	  in	  mind,	  we	  investigated	  the	  blood	  supply	  of	  the	  spinal	  cord	  and	  showed	  that	  
capillaries	  fail	  to	  develop	  normally	  in	  severe	  SMA	  mice.	  They	  do	  not	  show	  the	  rapid	  
increase	  in	  density,	  brought	  about	  by	  active	  angiogenesis,	  which	  occurs	  in	  white,	  and	  
more	  strikingly,	  in	  grey	  matter	  in	  littermate	  controls.	  This	  results	  in	  SMA	  ventral	  grey	  
matter	  having	  less	  than	  half	  the	  normal	  density	  of	  capillaries	  (Fig	  4B,C).	  Embryonic	  
development	  appears	  unaffected,	  as	  there	  are	  no	  differences	  at	  birth,	  rather	  a	  
failure	  to	  develop	  in	  the	  postnatal	  period	  after	  birth	  is	  suggested.	  Specifically,	  
growth	  of	  the	  capillary	  bed	  in	  SMA	  mice	  barely	  keeps	  pace	  with	  the	  growth	  of	  the	  
spinal	  cord,	  resulting	  in	  a	  consistently	  low	  density.	  This	  contrasts	  with	  unaffected	  
littermates	  where	  capillary	  growth	  outstrips	  spinal	  cord	  growth	  resulting	  in	  
significantly	  increased	  density.	  Importantly,	  this	  is	  also	  the	  case	  in	  a	  second	  mouse	  
model	  of	  SMA	  and	  specifically	  one	  generated	  using	  a	  different	  transgenic	  strategy	  to	  
include	  the	  delta	  7	  transgene	  and	  thereby	  avoiding	  positional	  effects	  (Fig	  4H,I).	  
This	  reduction	  in	  capillary	  density	  could	  contribute	  to	  the	  pathogenesis	  of	  SMA,	  
particularly	  the	  degeneration	  of	  motor	  neurons.	  A	  10-­‐15%	  reduction	  in	  the	  total	  
length	  and	  number	  of	  spinal	  cord	  capillaries	  results	  in	  a	  30-­‐45%	  reduction	  in	  spinal	  
cord	  blood	  flow	  37.	  A	  similar	  decreased	  perfusion	  of	  the	  cord	  occurs	  rapidly	  
subsequent	  to	  spinal	  cord	  injury	  38,	  and	  leads	  to	  motor	  neuron	  degeneration	  39.	  
	  
Early	  symptomatic	  severe	  mouse	  SMA	  spinal	  cord	  is	  significantly	  hypoxic	  
Given	  the	  importance	  of	  oxygenation	  for	  cell	  survival,	  we	  directly	  measured	  hypoxia	  
in	  early	  symptomatic	  spinal	  cord.	  In	  SMA,	  significant	  numbers	  of	  hypoxic	  cells	  were	  
present	  throughout	  spinal	  cord,	  and	  specifically	  there	  was	  an	  increase	  in	  the	  number	  
of	  hypoxic	  large,	  Nissl-­‐positive	  (likely)	  motor	  neurons	  at	  this	  early	  symptomatic	  time-­‐
point	  in	  ventral	  spinal	  cord	  (Fig	  5B,C,D).	  PIMO	  stain	  indicated	  oxygen	  concentrations	  
less	  than	  30%	  of	  normal	  levels	  in	  the	  CNS.	  This	  tissue	  hypoxia	  was	  observed	  at	  an	  
early	  stage	  in	  disease	  progression	  (P5),	  which	  is	  prior	  to	  or	  in-­‐line	  with	  the	  
appearance	  of	  neuromuscular	  pathology	  25	  15.	  Patient	  autopsies	  show	  markers	  of	  
oxidative	  stress	  in	  the	  motor	  neurons	  and	  brains	  of	  SMA	  patients	  40	  and	  oxidative	  
stress	  is	  a	  major	  cause	  of	  motor	  neuron	  death	  in	  clinically	  similar	  ALS	  41,	  42.	  PIMO	  is	  
rapidly	  cleared	  from	  the	  body	  by	  urinary	  excretion	  and	  therefore	  kidney	  function	  in	  
SMA	  mice	  is	  a	  relevant	  consideration.	  Only	  one	  study	  has	  directly	  assessed	  renal	  
function	  in	  the	  Taiwanese	  severe	  mouse	  model,	  and	  they	  found	  no	  significant	  
differences	  in	  two	  key	  markers	  of	  renal	  function:	  urea	  nitrogen	  and	  creatinine	  in	  
blood	  43.	  We	  therefore	  conclude	  that	  it	  is	  unlikely	  that	  altered	  renal	  function	  has	  
biased	  our	  interpretation	  of	  PIMO	  data	  in	  SMA	  mouse	  spinal	  cord.	  	  
The	  final	  form	  of	  the	  normal	  vascular	  system	  is	  widely	  considered	  to	  be	  barely	  
sufficient	  for	  the	  functioning	  of	  a	  healthy	  CNS	  44	  and	  given	  the	  relatively	  high	  
metabolic	  needs	  of	  the	  CNS	  45,	  the	  likely	  effects	  of	  chronic	  hypoxia	  due	  to	  
hypovascularity	  are	  significant.	  Deletion	  of	  the	  hypoxia	  response	  element	  in	  mice,	  
diminished	  vascular	  perfusion	  and	  triggered	  degeneration	  of	  30%	  of	  ventral	  horn	  
motor	  neurons	  39.	  These	  mice	  presented	  with	  severe	  muscle	  weakness	  and	  an	  ALS-­‐
phenotype	  with	  hindlimb	  clasping,	  muscle	  weakness	  and	  progressive	  immobility	  39.	  
Hypoxia	  is	  therefore	  demonstrated	  to	  be	  a	  risk	  factor	  in	  triggering	  motor	  neuron	  
degeneration,	  and	  likely	  contributes	  to	  motor	  pathology	  in	  SMA.	  
	  
Spinal	  cord	  hypoxia	  is	  predicted	  to	  have	  additional,	  negative	  effects	  on	  disease	  
progression	  
Aside	  from	  obvious	  deleterious	  effects	  on	  cell	  metabolism	  and	  survival,	  hypoxia	  also	  
has	  a	  negative	  effect	  upon	  SMN	  splicing,	  by	  increasing	  levels	  of	  exon	  7	  skipping	  in	  
the	  SMN2	  gene	  46,	  which	  would	  be	  expected	  to	  result	  in	  further	  depletion	  of	  SMN	  
levels	  in	  hypoxic	  tissue.	  This	  suggests	  that	  hypoxia	  could	  be	  a	  major	  modulator	  of	  
SMN	  protein	  levels,	  the	  main	  determinant	  of	  disease	  severity	  47.	  Furthermore	  it	  has	  
been	  shown	  that	  reactive	  oxygen	  species,	  generated	  during	  hypoxia,	  inhibit	  SMN	  
complex	  activity	  in	  a	  dose-­‐dependent	  manner;	  specifically	  it	  is	  proposed	  that	  
SMNΔ7,	  the	  major	  protein	  product	  of	  SMN2	  may	  be	  particularly	  vulnerable	  to	  
oxidative	  stress	  48.	  Major	  changes	  in	  gene	  transcription	  occur	  in	  the	  SMA	  late	  
symptomatic	  spinal	  cord	  49,	  suggestive	  of	  significant,	  ongoing	  developmental	  
anomalies	  such	  as	  these.	  A	  situation	  may	  therefore	  exist	  whereby	  reduced	  SMN	  
protein	  levels	  induce	  a	  hypoxic	  state	  due	  to	  morphological	  vascular	  defects,	  which	  in	  
turn	  causes	  a	  reduction	  in	  SMN	  protein	  levels	  and	  further	  exacerbates	  disease	  
progression.	  	  
	  
The	  protein	  composition	  of	  the	  blood	  spinal	  cord	  barrier	  is	  defective	  in	  SMA	  mice	  
The	  blood	  brain	  barrier	  is	  key	  to	  maintain	  the	  ‘protected’	  status	  of	  the	  CNS.	  In	  SMA	  
only	  Claudin-­‐5,	  a	  component	  of	  endothelial	  cell	  tight	  junctions,	  did	  not	  completely	  
co-­‐localise	  with	  blood	  vessels,	  particularly	  in	  smaller	  vessels	  (Fig	  6),	  suggesting	  
incomplete	  formation	  of	  the	  BSCB.	  Once	  again,	  this	  indicates	  a	  post-­‐natal	  failure	  in	  
development	  and	  maturation	  of	  blood	  vessels,	  where	  the	  smallest	  and	  presumed	  
recently	  formed	  vessels	  do	  not	  acquire	  full	  barrier	  properties.	  	  
Mice	  maintained	  in	  hypoxic	  conditions	  develop	  a	  41%	  decrease	  in	  Claudin-­‐5	  protein	  
expression,	  in	  the	  blood	  retinal	  barrier,	  resulting	  in	  leakage	  50.	  We	  suggest	  that	  the	  
hypoxia	  we	  see	  at	  P5	  has	  at	  least	  partly	  driven	  the	  defects	  observed	  in	  the	  BSCB	  at	  
P11.	  The	  particular	  sensitivity	  of	  Claudin-­‐5	  to	  hypoxia	  could	  explain	  why	  it	  appears	  to	  
be	  the	  only	  BSCB	  component	  affected	  in	  SMA.	  This	  could	  in	  turn	  be	  a	  factor	  in	  motor	  
neuron	  damage	  resulting	  via	  a	  leaky	  BSCB	  30.	  	  
	  
Changing	  perceptions	  
SMA	  has	  traditionally	  been	  viewed	  as	  a	  disease	  of	  lower	  motor	  neurons,	  with	  the	  
development	  of	  therapeutic	  interventions	  for	  many	  years	  focused	  on	  maintaining	  or	  
replacing	  motor	  neurons	  51,	  based	  on	  the	  concept	  that	  they	  are	  selectively	  
vulnerable	  16.	  Our	  data	  suggest	  that	  hypoxia,	  driven	  by	  primary	  vascular	  defects,	  may	  
contribute	  to	  this	  vulnerability.	  Here,	  motor	  neurons	  become	  highly	  active	  in	  the	  
post-­‐natal	  period	  and	  oxygen	  demand	  is	  not	  met	  by	  a	  defective	  vasculature,	  leading	  
to	  metabolic	  failure	  and	  the	  production	  of	  oxygen	  radicals,	  which	  together	  result	  in	  
motor	  neuron	  dysfunction	  and	  death.	  Added	  to	  this	  the	  negative	  effects	  of	  hypoxia	  
on	  BSCB	  integrity	  and	  SMN	  splicing,	  produces	  a	  perfect	  storm	  of	  factors	  deleterious	  
to	  motor	  neurons.	  Cardiovascular	  phenotypes,	  including	  cardiac	  muscle	  capillary	  
defects,	  are	  now	  well	  documented	  in	  SMA	  with	  morphological	  and	  functional	  defects	  
reported	  clinically	  and	  experimentally	  5,	  12,	  52-­‐54.	  In	  addition,	  we	  have	  now	  shown	  
significant	  vascular	  defects	  in	  patients	  with	  severe	  SMA.	  It	  is	  therefore	  possible	  that	  
capillary	  defects	  could	  contribute	  to	  muscle	  wasting,	  motor	  neuron	  loss	  and	  the	  
appearance	  of	  clinical	  symptoms,	  at	  least	  patients	  with	  severe	  SMA.	  This	  shift	  in	  
perspective	  regarding	  the	  nature	  of	  SMA	  pathology	  has	  major	  implications	  for	  future	  
therapeutic	  development.	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Capillary	  density	  is	  reduced	  in	  the	  skeletal	  muscle	  of	  the	  proximal	  forelimbs	  of	  
early	  symptomatic	  SMA	  mice	  
Representative	  micrographs	  of	  capillaries	  labeled	  with	  the	  endothelial	  cell	  marker	  
Griffonia	  simplicifolia	  Lectin-­‐1	  (GSL-­‐1:	  55	  red),	  in	  transverse	  sections	  of	  proximal	  
forelimb	  muscle	  from	  P8	  Taiwanese	  in	  (A)	  control	  and	  (B)	  SMA	  mice.	  (C)	  
Quantification	  of	  capillary	  density	  expressed	  as	  a	  percentage	  of	  cross-­‐sectional	  
muscle	  area	  showed	  that	  SMA	  muscle	  was	  significantly	  less	  capillary-­‐dense	  (2.97%)	  
compared	  with	  control	  mice	  (6.22%	  ***	  P<0.001	  unpaired,	  two-­‐tailed	  t-­‐test).	  (D)	  
Alternatively,	  calculating	  the	  ratio	  of	  capillaries	  to	  muscle	  fiber	  profiles	  in	  transverse	  
sections	  of	  whole	  proximal	  forelimbs	  (mean	  ±	  s.e.m.)	  confirmed	  and	  extended	  our	  
findings,	  demonstrating	  a	  significantly	  decreased	  (<40%)	  capillary/muscle	  fiber	  ratio	  
in	  SMA	  mice	  (0.25)	  compared	  with	  control	  littermates	  (0.68:	  ***	  P<0.001	  unpaired,	  
two-­‐tailed	  t-­‐test).	  n≥3	  mice	  and	  n≥250	  muscle	  cross	  sections	  per	  group.	  (E)	  The	  
number	  of	  intra-­‐muscular	  arterioles	  (defined	  as	  vessels	  expressing	  α-­‐SMActin)	  
appeared	  reduced	  in	  SMA	  mice.	  We	  counted	  the	  number	  of	  intra-­‐muscular	  vessels	  
expressing	  α-­‐SMActin	  in	  transverse-­‐sections	  of	  whole	  proximal	  forelimb.	  There	  was	  a	  
significant	  (~57%)	  decrease	  in	  the	  mean	  number	  of	  intra-­‐muscular	  arterioles:	  33.6	  
vessels/section	  in	  control	  mice	  to	  14.3	  vessels/section	  in	  SMA	  mice	  (***P<0.001	  
unpaired,	  two-­‐tailed	  t-­‐test).	  	  
Scale	  bar	  =	  50µm	  
	  
Figure	  2	  
Capillary	  density	  is	  reduced	  in	  skeletal	  muscle	  biopsies	  from	  severe	  SMA	  patients	  
We	  obtained	  skeletal	  muscle	  biopsies	  from	  diagnostically	  confirmed	  severe	  SMA	  
patients	  and	  control	  individuals	  with	  no	  vascular	  or	  neuromuscular	  disease.	  These	  
were	  processed	  for	  immunocytochemistry	  and	  capillary:	  fibre	  ratio	  calculated,	  as	  for	  
mouse	  experiments.	  Muscles	  were	  co-­‐stained	  with	  laminin	  to	  reveal	  muscle	  fibre	  
profiles	  and	  PECAM	  1	  to	  show	  blood	  vessels.	  (A)	  Control	  muscle	  (25	  mo)	  shows	  a	  
typical	  young/	  juvenile	  arrangement,	  where	  each	  capillary	  is	  close	  to	  1-­‐2	  muscle	  
fibres,	  resulting	  in	  a	  mean	  capillary:	  fibre	  ratio	  of	  0.78:1.	  (B)	  SMA	  muscle	  (24	  mo)	  
shows	  a	  decreased	  number	  of	  capillaries,	  resulting	  in	  most	  muscle	  fibres	  being	  more	  
distant	  from	  a	  capillary,	  and	  a	  mean	  capillary:	  fibre	  ratio	  of	  0.08:1.	  (C)	  Data	  from	  a	  
range	  of	  control	  children	  (mean	  ±SEM)	  and	  SMA	  patients	  reveals	  a	  steady	  increase	  in	  
vascularity	  in	  normal	  controls,	  but	  a	  failure	  to	  effectively	  vascularize	  in	  SMA	  over	  a	  
36	  month	  period.	  Regression	  analysis	  of	  the	  slope	  of	  change	  in	  vascularity	  with	  
increasing	  age,	  indicated	  that	  there	  was	  a	  significant	  difference	  between	  control	  and	  
SMA	  muscle	  biopsies.	  
n=9	  Control,	  n=7	  SMA	  patients	  and	  3-­‐9	  (mean=5)	  sections	  per	  patient.***	  P<0.001,	  	  
Scale	  bar	  A	  =	  25µm	  
	   	  
Figure	  3	  
Spinal	  cord	  capillary	  bed	  density	  increases	  from	  birth	  to	  3	  weeks	  post-­‐natal	  in	  wild-­‐
type	  spinal	  cord	  
Counts	  of	  capillary	  density	  in	  C57Bl	  wild-­‐type	  mice	  were	  pooled	  from	  left	  and	  right	  
spinal	  cord	  hemisections,	  as	  they	  were	  not	  significantly	  different.	  There	  were	  also	  no	  
significant	  differences	  between	  thoracic	  and	  limb-­‐regions	  of	  the	  spinal	  cord,	  and	  all	  
the	  following	  data	  are	  drawn	  from	  thoracic	  spinal	  cord.	  (A)	  Capillary	  density	  assessed	  
by	  quantitation	  of	  PECAM-­‐1	  immunostaining	  in	  C57Bl	  wild-­‐type	  mice	  between	  P3-­‐
P21.	  Bars	  represent	  mean	  ±	  s.e.m.	  The	  total	  capillary	  density	  of	  the	  spinal	  cord	  
significantly	  increased	  between	  each	  age	  (one-­‐way	  ANOVA	  with	  Tukey	  post-­‐hoc	  test:	  
***P<0.001).	  Each	  bar	  represents	  data	  from	  3	  mice,	  ≥30	  sections	  and	  ≥480	  fields	  of	  
view.	  (B)	  Scatter	  plots	  show	  a	  significant	  increase	  (~15%)	  in	  capillary	  caliber	  between	  
P3	  and	  P21	  (unpaired	  two	  tailed	  t-­‐test:	  ***P<0.001).	  n=3	  mice	  and	  ≥500	  capillary	  
profiles	  for	  each	  time-­‐point.	  (C)	  Differentiation	  of	  grey	  (black	  bars)	  and	  white	  (white	  
bars)	  matter	  in	  dorsal	  (D)	  and	  ventral	  (V)	  regions	  of	  spinal	  cord	  using	  cresyl	  violet	  
revealed	  that	  grey	  matter	  becomes	  significantly	  more	  capillary-­‐dense	  than	  white	  
matter	  over	  time	  (one-­‐way	  ANOVA	  and	  Tukey	  post-­‐hoc	  test:	  ***P<0.001.	  n=3	  mice	  
per	  age	  group	  and	  ≥30	  sections	  per	  time-­‐point.	  
	   	  
Figure	  4	  
Capillary	  density	  is	  depleted	  in	  SMA	  spinal	  cord	  
Representative	  montage	  micrographs	  of	  sections	  from	  Taiwanese	  P11	  (A)	  control	  
and	  (B)	  SMA	  spinal	  cord	  visualised	  with	  PECAM	  1	  (shown	  black)	  in	  Taiwanese	  severe	  
SMA	  mice.	  Individual	  images	  used	  to	  construct	  the	  montages	  were	  taken	  at	  10x	  
magnification.	  (C)	  Bar	  chart	  (mean	  ±	  s.e.m.)	  of	  quantification	  of	  capillary	  density	  in	  
the	  spinal	  cord	  from	  P0	  to	  P11	  in	  Taiwanese	  control	  littermates	  and	  SMA	  mice.	  One-­‐
way	  ANOVA	  with	  Tukey	  post-­‐hoc	  test:	  NS	  P>0.05;	  ***P<0.001.	  n≥3	  mice	  and	  n≥3	  
spinal	  cords	  for	  each	  bar.	  (D,E,F,G)	  Capillary	  density	  is	  reduced	  in	  all	  four	  spinal	  cord	  
regions	  and	  in	  both	  grey	  and	  white	  matter	  in	  P11	  Taiwanese	  SMA	  mice.	  Bar	  charts	  
(mean	  +	  s.e.m.)	  show	  quantification	  of	  capillary	  density	  in	  the	  spinal	  cord	  of	  P11	  
Taiwanese	  SMA	  mice	  and	  control	  littermates.	  Unpaired,	  two-­‐tailed	  t-­‐test:	  **P<0.01;	  
***P<0.001.	  n≥3	  mice	  and	  n≥3	  cords	  for	  each	  bar.	  (H)	  Representative	  montage	  
micrograph	  of	  P14	  control	  and	  	  (I)	  SMA	  spinal	  cord	  capillary	  bed	  visualised	  with	  
PECAM-­‐1	  in	  SMNΔ7	  mice.	  Individual	  images	  used	  to	  construct	  montage	  are	  10x	  
magnification.	  (J)	  Bar	  chart	  (mean	  ±	  s.e.m.)	  quantification	  of	  overall	  spinal	  cord	  
capillary	  density	  in	  P14	  SMNΔ7	  SMA	  mice	  and	  control	  littermates.	  White	  bars	  =	  
control	  and	  black	  bars	  =	  SMA	  mice.	  Unpaired,	  two	  tailed	  t-­‐test,	  ***P<0.001.	  n≥3	  
mice	  and	  n≥3	  cords	  for	  each	  bar.	  	  
Scale	  bar	  =	  200	  μm.	  
	   	  
Figure	  5	  
Diffusion	  distances	  are	  increased	  and	  cells	  and	  tissue	  are	  hypoxic	  in	  the	  ventral	  
horn	  of	  the	  spinal	  cord	  
The	  number	  of	  capillaries	  surrounding	  motor	  neurons	  is	  reduced	  in	  late	  symptomatic	  
Taiwanese	  SMA	  mice.	  (A)	  Representative	  micrographs	  of	  motor	  neurons	  labelled	  
with	  SM1-­‐32	  (green)	  and	  the	  capillary	  bed	  with	  PECAM	  1	  (red)	  in	  control	  and	  late	  
symptomatic	  P11	  Taiwanese	  SMA	  spinal	  cords.	  Images	  are	  20x	  magnification.	  (B)	  
Representative	  micrographs	  of	  DAB	  visualisation	  of	  PIMO-­‐labelled	  hypoxic	  cells	  in	  
ventral	  horn	  of	  P5	  control	  littermates	  and	  early	  symptomatic	  Taiwanese	  SMA	  mice.	  A	  
diaminobenzidine	  (DAB:	  brown)	  reaction	  product	  indicates	  cells	  which	  were	  in	  an	  
environment	  of	  <10	  mm	  Hg	  at	  the	  time	  of	  PIMO	  injection.	  Spinal	  cords	  were	  
counterstained	  with	  cresyl	  fast	  violet.	  Images	  are	  40x	  magnification.	  (C)	  To	  highlight	  
the	  PIMO	  positive	  hypoxic	  cells,	  we	  have	  thresholded	  and	  inverted	  the	  images	  to	  
demonstrate	  the	  increase	  in	  the	  number	  of	  hypoxic	  cells	  (white)	  in	  SMA	  spinal	  cord.	  
(D)	  Quantification	  revealed	  significantly	  increased	  number	  of	  hypoxic	  cells	  in	  the	  
ventral	  region	  of	  P5	  Taiwanese	  SMA	  spinal	  cord.	  Bar	  chart	  (mean	  ±	  s.e.m.)	  of	  hypoxic	  
cells	  (per	  unit	  area)	  in	  ventral	  horn	  of	  P5	  control	  littermates	  (white	  bar),	  and	  
symptomatic	  Taiwanese	  SMA	  mice	  (black	  bar).	  Unpaired,	  two-­‐tailed	  t-­‐test.	  
***P<0.001	  n≥3	  mice,	  n≥3	  cords,	  n≥27	  sections	  and	  n≥54	  images	  for	  each	  bar.	  
Scale	  bar	  =	  50	  µm.	  
	   	  
Figure	  6	  
The	  blood	  spinal	  cord	  barrier	  develops	  aberrantly	  in	  SMA	  spinal	  cord	  	  
Claudin-­‐5	  (CL-­‐5)	  labelling	  is	  disrupted	  in	  P11	  Taiwanese	  SMA	  mice,	  while	  aquaporin-­‐4	  
(AQ-­‐4)	  and	  zona	  occludens-­‐1	  (ZO-­‐1)	  both	  appear	  normal.	  Representative	  
micrographs	  of	  P11	  Taiwanese	  SMA	  and	  control	  spinal	  cord	  visualised	  with	  GSL-­‐1	  to	  
indicate	  capillaries	  (red)	  and	  co-­‐labelled	  with	  AQ-­‐4,	  CL-­‐5	  or	  ZO-­‐1	  (green).	  
Arrowheads	  indicate	  capillaries	  negative	  for	  CL-­‐5.	  	  
Scale	  bar	  =	  50	  µm.	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